Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Highly Anticipated, Genetic Ink, Launches DNA Art Platform; Builds on Advances in Biotechnology [Infographic]
  • USA - English


News provided by

Genetic Ink

Apr 24, 2014, 08:00 ET

Share this article

Share toX

Share this article

Share toX

Infographic - Genetic Ink follows a history of major achievements in biotechnology, art and culture. Discover that story here.
Infographic - Genetic Ink follows a history of major achievements in biotechnology, art and culture. Discover that story here.

Just as Pixar became the stewards of computing to the animation world, we intend to become the stewards of biotechnology and genetic sequencing to the art world.

Post this

New York, NY (PRWEB) April 24, 2014 -- After a media frenzied reception around its announcement in March, New York startup Genetic Ink is launching its first DNA Art collaboration, Spark, today. With recent advances in biotechnology driving the cost of genetic sequencing down, Genetic Ink has developed a technology that is able to combine any human, cat, or dog DNA sequence with an artist’s concept. The result is a 100% unique piece of art for each subject. The company aims to become a platform for top artists and designers to express themselves with DNA sequence data, and to make that art available to the public.

The concept of art from DNA first came to public attention, when renowned American artist Dennis Ashbaugh began painting “genetic portraits” in 1985. The oversized canvases were created in the tradition of Pollack and Mondrian, but closely followed the aesthetic of then-new DNA electrophoresis gels. These gels allowed for nominal visual representation of the DNA, but did not actually depict the DNA sequence.

Since then, the development of painless, at-home cheek swab DNA collection has allowed a number of companies to commercialize Ashbaugh’s concept. By contrast, Genetic Ink opens a new chapter in the history of DNA Art. It is the first company to actually sequence DNA and work with artists to create DNA Art concepts that look unlike others before them. Whereas all DNA electrophoresis derived art looks the same, Genetic Ink takes collaborative artists’ concepts and turns them into generative algorithms, capable of producing completely unique works of art from each individual’s DNA sequence. As increasingly robust genetic sequencing methods become commercially viable, the company has taken upon itself to give artists as much expressive potential as possible.

CEO and co-founder, Kishan Bhoopalam, a former neuroscience researcher states, “just as Pixar became the stewards of computing to the animation world, we intend to become the stewards of biotechnology and genetic sequencing to the art world. We want to constantly push the envelope and stun people with beauty of a kind they never realized was possible.”

In addition to arousing media fascination in March, the company invited several media influencers to create their DNA Art before launch.

New York Times bestseller Jay Baer created a piece of art from his dog’s DNA. Baer says, “[it’s] the most interesting thing you can put on your wall… the ultimate conversation starter.”

Editor-in-Chief of high-fashion and art publication Bloginity.com, Daniel Haim, says, “Nothing expresses unique, one-of-a-kindness better than your final DNA Art... pleasantly surprised by its quality and ultra-fine materials.”

Spark, a collaboration with Swiss-Canadian artist Mathieu Daudelin, is available in 4 sizes and 17 color schemes, starting at $200 at GeneticInk.com. Each piece of DNA Art includes a cotton cheek swab DNA collection kit, also designed by Daudelin, which works for adults, children, and pets. The kit is returned to Genetic Ink's CLIA-certified lab, where it undergoes fully anonymized sequencing. That sequence is fed into the Spark Art Style algorithm, and the resulting DNA Art is printed onto heavy, gallery-quality canvas.

In conjunction with the launch, the company has created an infographic, "How DNA Became Art - An Art and Science Love Story" to educate the public of the scientific, artistic and cultural achievements that have made DNA Art possible, which you can see here.

About Genetic Ink

Genetic Ink is the art meets science company. They collaborate with leading artists and engineers to create unique fine art from biological data. Genetic Ink seeks to inspire awe and wonder of the natural world by illuminating it through the lenses of art and science.

Genetic Ink is the first company to create true DNA Art, artist-driven, gallery-quality art from sequenced human and animal DNA.

About Kishan Bhoopalam - CEO

Kishan Bhoopalam is an Indian-American biotechnology entrepreneur and CEO of Genetic Ink. Bhoopalam was previously a neuroscience researcher and co-founded a nutraceutical venture.

About Mathieu Daudelin – Collaborating Artist, Spark

Mathieu Daudelin is a Swiss-Canadian artist and designer and graduate of l'Ecole cantonale d'art de Lausanne. His creative aspirations are to better understand the world around him.

His work explores visual language and manipulation of different materials to express ideas. It focuses on the creative process, deriving as much meaning from experimentation and exploration as from the final product itself.

Alex Pyatetsky, Genetic Ink, http://www.geneticink.com, +1 3129700637, [email protected]

Modal title

Genetic Ink's first DNA Art collaboration with Swiss-Canadian artist Mathieu Daudelin, Spark, comes in 17 color schemes.
Genetic Ink's first DNA Art collaboration with Swiss-Canadian artist Mathieu Daudelin, Spark, comes in 17 color schemes.
Genetic Ink's first DNA Art Style "Spark" - Family Room Installation
Genetic Ink's first DNA Art Style "Spark" - Family Room Installation
Genetic Ink's first DNA Art Style "Spark" in the office of Vice's Mike Germano
Genetic Ink's first DNA Art Style "Spark" in the office of Vice's Mike Germano
Genetic Ink doesn't just create DNA Art, but a beautiful experience for its customers.
Genetic Ink doesn't just create DNA Art, but a beautiful experience for its customers.
Customers co-create your their air by choosing from 3 types of DNA, 17 color schemes, and 4 canvas sizes.
Customers co-create your their air by choosing from 3 types of DNA, 17 color schemes, and 4 canvas sizes.
Infographic - Genetic Ink follows a legacy of major achievements in biotechnology, art and culture. This is that story.
Infographic - Genetic Ink follows a legacy of major achievements in biotechnology, art and culture. This is that story.
Genetic Ink's first DNA Art collaboration with Swiss-Canadian artist Mathieu Daudelin, Spark, comes in 17 color schemes. Genetic Ink's first DNA Art Style "Spark" - Family Room Installation Genetic Ink's first DNA Art Style "Spark" in the office of Vice's Mike Germano Genetic Ink doesn't just create DNA Art, but a beautiful experience for its customers. Customers co-create your their air by choosing from 3 types of DNA, 17 color schemes, and 4 canvas sizes. Infographic - Genetic Ink follows a legacy of major achievements in biotechnology, art and culture. This is that story.

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.